Alternatives to methylphenidate
FDA shortage status is active for methylphenidate; 3 same-class SPL records are listed below for registry comparison only.
Brand: Ritalin, Concerta
methylphenidate class peers while FDA lists an active shortage
methylphenidate (Ritalin, Concerta) is on an FDA shortage listing while 3 other CNS Stimulant SPL records remain in this registry peer set (class inventory 4). Labeled indication field for methylphenidate: This medicine treats Attention Deficit Hyperactivity Disorder (ADHD) in children.
Top FAERS reaction fields for methylphenidate total 16,953 reports across 10 reactions, set beside amphetamine/dextroamphetamine, dexmethylphenidate, lisdexamfetamine. Counts are exposure-weighted submissions, not per-patient risk.
About methylphenidate
Methylphenidate extended-release capsules are a stimulant medicine. They are used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 to 12.
Used for: This medicine treats Attention Deficit Hyperactivity Disorder (ADHD) in children. ADHD can make it hard to focus, pay attention, and control impulsive behavior. This medicine can help improve focus and reduce hyperactivity.
3 CNS Stimulant peers (wide set)
amphetamine/dextroamphetamine
RxAdderall, Adderall XR
Adderall XR treats attention deficit hyperactivity disorder (ADHD) in adults and kids 6 years and older. ADHD can make it hard to focus, pay attention, and control impulsive behavior. This medicine can help improve focus and reduce impulsivity.
dexmethylphenidate
RxFocalin, Focalin XR
AZSTARYS is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in people 6 years and older. ADHD can make it hard to focus, pay attention, and control impulsive behaviors. This medicine can help manage these symptoms.
lisdexamfetamine
RxVyvanse
This medicine treats Attention Deficit Hyperactivity Disorder (ADHD) in adults and kids 6 years and older. It also treats moderate to severe binge eating disorder (BED) in adults. This medicine is not for weight loss.
Compare methylphenidate vs amphetamine/dextroamphetamine side-by-side →
methylphenidate vs amphetamine/dextroamphetamine & dexmethylphenidate · FAERS reaction fields
FAERS top-reaction field "Product Quality Issue" shows the widest count spread between methylphenidate and amphetamine/dextroamphetamine, dexmethylphenidate, lisdexamfetamine in this extract (5,139-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | methylphenidate | amphetamine/dextroamphetamine | dexmethylphenidate | lisdexamfetamine |
|---|---|---|---|---|
| Product Quality Issue | 5,241 | - | 102 | - |
| Drug Administration Error | 1,901 | - | - | - |
| Wrong Technique In Drug Usage Process | 1,772 | - | - | - |
| Application Site Erythema | 1,684 | - | - | - |
| Drug Dose Omission | 1,478 | - | - | - |
| Incorrect Drug Administration Duration | 1,191 | - | - | - |
| Drug Prescribing Error | 1,079 | - | - | - |
| Disturbance In Attention | 907 | - | 155 | - |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
methylphenidate shortage vs CNS Stimulant peer index
Shortage status
FDA shortage listing is active for methylphenidate (status: Current). Peer rows remain a registry index, not a switch guide.
Frequently Asked Questions
Does FDA list a shortage for methylphenidate while peers remain indexed? ▼
Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for methylphenidate: see also the generic vs brand label guide when reading Ritalin SPL strings.
Read our methodology - how this data is sourced, computed, and verified.